DE69407057D1 - 1,3.5 (10) - estratriene derivate mit oraler wirkung - Google Patents

1,3.5 (10) - estratriene derivate mit oraler wirkung

Info

Publication number
DE69407057D1
DE69407057D1 DE69407057T DE69407057T DE69407057D1 DE 69407057 D1 DE69407057 D1 DE 69407057D1 DE 69407057 T DE69407057 T DE 69407057T DE 69407057 T DE69407057 T DE 69407057T DE 69407057 D1 DE69407057 D1 DE 69407057D1
Authority
DE
Germany
Prior art keywords
estratria
derivatives
beta
oral effect
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69407057T
Other languages
English (en)
Other versions
DE69407057T2 (de
Inventor
Hyun Kim
Richard Blye
Gabriel Bialy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69407057D1 publication Critical patent/DE69407057D1/de
Publication of DE69407057T2 publication Critical patent/DE69407057T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE69407057T 1993-09-17 1994-09-15 1,3.5 (10) - estratriene derivate mit oraler wirkung Expired - Lifetime DE69407057T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/122,853 US5554603A (en) 1993-09-17 1993-09-17 Orally active derivatives of 1,3,5(10)-estratriene
PCT/US1994/010393 WO1995007925A1 (en) 1993-09-17 1994-09-15 Orally active derivatives of 1,3,5(10)-estratriene

Publications (2)

Publication Number Publication Date
DE69407057D1 true DE69407057D1 (de) 1998-01-08
DE69407057T2 DE69407057T2 (de) 1998-04-09

Family

ID=22405185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407057T Expired - Lifetime DE69407057T2 (de) 1993-09-17 1994-09-15 1,3.5 (10) - estratriene derivate mit oraler wirkung

Country Status (11)

Country Link
US (1) US5554603A (de)
EP (1) EP0719276B1 (de)
JP (1) JP3993228B2 (de)
AT (1) ATE160573T1 (de)
AU (1) AU700576B2 (de)
CA (1) CA2171740C (de)
DE (1) DE69407057T2 (de)
DK (1) DK0719276T3 (de)
ES (1) ES2110258T3 (de)
GR (1) GR3025872T3 (de)
WO (1) WO1995007925A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503896B1 (en) 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
EP1603933A2 (de) * 2003-03-13 2005-12-14 Nitromed, Inc. Nitrosierte und nitrosylierte verbindungen, zusammensetzungen und deren anwendungen
AU2005247948A1 (en) * 2004-05-27 2005-12-08 Migenix Corp. 2-substituted 17-imino estrogen compounds for cytoprotection
US7960368B2 (en) * 2008-03-05 2011-06-14 Everstra, Inc. Bismethylene-17A carbolactones and related uses
CA2725578A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
US8222237B2 (en) * 2008-11-25 2012-07-17 Evestra, Inc. Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones
RU2648827C2 (ru) * 2010-03-28 2018-03-28 Эвестра, Инк. Внутривлагалищное устройство для доставки лекарственного средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1074493A (en) * 1963-06-12 1967-07-05 Roussel Uclaf Novel estrane derivatives and processes for preparing them
FR5241M (de) * 1966-02-24 1967-07-17
NL135316C (de) * 1966-11-18
US3980681A (en) * 1969-11-21 1976-09-14 Peter Job Sykes Process for the preparation of 11-β-nitro-oxysteroids
GB1332784A (en) * 1969-11-21 1973-10-03 Glaxo Lab Ltd Nitrates of steroid 11 beta-ols
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes

Also Published As

Publication number Publication date
EP0719276B1 (de) 1997-11-26
JP3993228B2 (ja) 2007-10-17
WO1995007925A1 (en) 1995-03-23
DE69407057T2 (de) 1998-04-09
CA2171740C (en) 2005-07-26
DK0719276T3 (da) 1998-08-10
US5554603A (en) 1996-09-10
AU7728494A (en) 1995-04-03
GR3025872T3 (en) 1998-04-30
ATE160573T1 (de) 1997-12-15
CA2171740A1 (en) 1995-03-23
ES2110258T3 (es) 1998-02-01
EP0719276A1 (de) 1996-07-03
AU700576B2 (en) 1999-01-07
JPH09505802A (ja) 1997-06-10

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
NL193616B (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
ES2181744T3 (es) Hidratos de paclitaxel cristalinos.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
MX9601994A (es) Profarmacos de derivados de paclitaxel.
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
SE9604348D0 (sv) Användning av hydroxyguanidiner
DE69407057T2 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
MX9200748A (es) Formulaciones de esteroides. formulaciones de esteroides.
DE69602886D1 (de) Im kardiovaskulären System aktive seco-D-Steroide und diese enthaltende pharmazeutische Zubereitungen
ATE227122T1 (de) Stabilisierte tablettenformulierung
ZA929879B (en) Compositions for the treatment of mammalian diseases.
FI923751A (fi) Hexahydrobenso/f/kinolinoner
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
MX9202293A (es) Composicion de vacuna no-irritante.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: ACKMANN MENGES PATENT- UND RECHTSANWAELTE, 80469 M

R082 Change of representative

Ref document number: 719276

Country of ref document: EP

Representative=s name: SCHUMACHER & WILLSAU PATENTANWALTSGESELLSCHAFT, DE